Abstract:Seneca virus A (SVA) is an emerging novel picornavirus that has recently been identified as the causative agent of many cases of porcine vesicular diseases in multiple countries. In addition to cleavage of viral polyprotein, the viral 3C protease (3C pro ) plays an important role in the regulation of several physiological processes involved in cellular antiviral responses by cleaving critical cellular proteins. Through a combination of crystallography, untargeted lipidomics, and immunoblotting, we identified the association of SVA 3C pro with an endogenous phospholipid molecule, which binds to a unique region neighboring the proteolytic site of SVA 3C pro . Our lipid-binding assays showed that SVA 3C pro displayed preferred binding to cardiolipin (CL), followed by phosphoinositol-4-phosphate (PI4P) and sulfatide. Importantly, we found that the proteolytic activity of SVA 3C pro was activated in the presence of the phospholipid, and the enzymatic activity is inhibited when the phospholipid-binding capacity decreased. Interestingly, in the wild-type SVA 3C pro -substrate peptide structure, the cleavage residue cannot form a covalent binding to the catalytic cysteine residue to form the acyl-enzyme intermediate observed in several picornaviral 3C pro structures. We observed a decrease in infectivity titers of SVA mutants harboring mutations that impaired the lipid-binding ability of 3C pro , indicating a positive regulation of SVA infection capacity mediated by phospholipids. Our findings reveal a mutual regulation between the proteolytic activity and phospholipid-binding capacity in SVA 3C pro , suggesting that endogenous phospholipid may function as an allosteric activator that regulate the enzyme's proteolytic activity during infection. Seneca virus A (SVA) is a novel picornavirus and there have been several recent outbreaks that caused a great threat to the swine industry in some countries. The protease 3C pro is responsible for the cleavage of viral polyprotein and it can also cleave several host proteins enabling SVA to escape antiviral innate immune responses. We identified an endogenous phospholipid molecule that binds to a unique region in SVA 3C pro by a combination of crystallography, untargeted lipidomics, and immunoblotting. The preferred phospholipid types include cardiolipin, phosphoinositol-4-phosphate and sulfatide. We found the protease activity can be significantly inhibited when the phospholipid-binding capacity decreases. Meanwhile, a decrease in infectivity titers of SVA mutants harboring mutations that impair the lipid-binding ability of 3C pro was observed. Our findings suggest the phospholipid may function as an allosteric activator to regulate SVA 3C pro proteolytic activity associated with the viral replication and infection.

Seneca valley virus 3C protease blocks EphA2-Mediated mTOR activation to facilitate viral replication

Seneca Valley virus 3C pro antagonizes type I interferon response by targeting STAT1-STAT2-IRF9 and KPNA1 signals

Seneca Valley virus 3C pro degrades heterogeneous nuclear ribonucleoprotein A1 to facilitate viral replication

Seneca Valley Virus 3Cpro Cleaves Heterogeneous Nuclear Ribonucleoprotein K to Facilitate Viral Replication

Seneca Valley Virus 3C Protease Negatively Regulates the Type I Interferon Pathway by Acting As a Viral Deubiquitinase

Seneca Valley virus 3Cpro antagonizes host innate immune responses and programmed cell death

Synergetic contributions of viral VP1, VP3, and 3C to activation of the AKT-AMPK-MAPK-MTOR signaling pathway for Seneca Valley virus-induced autophagy

Seneca Valley Virus 3cpro Abrogates the IRF3- and IRF7-mediated Innate Immune Response by Degrading IRF3 and IRF7.

Seneca Valley Virus 3C Protease Inhibits Stress Granule Formation by Disrupting Eif4gi-G3bp1 Interaction

Selective autophagy receptor SQSTM1/ p62 inhibits Seneca Valley virus replication by targeting viral VP1 and VP3

Impaired interferon response in senecavirus A infection and identification of 3Cpro as an antagonist

Seneca Valley virus 3C protease cleaves OPTN (optineurin) to Impair selective autophagy and type I interferon signaling

Seneca Valley Virus 2C and 3C Inhibit Type I Interferon Production by Inducing the Degradation of RIG-I.

Seneca Valley Virus 2C and 3C pro Induce Apoptosis via Mitochondrion-Mediated Intrinsic Pathway.

Senecavirus A 2B Protein Suppresses Type I Interferon Production by Inducing the Degradation of MAVS.

Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.

Seneca Valley virus enters cells through multiple pathways and traffics intracellularly via the endolysosomal pathway

Seneca Valley Virus Degrades STING via PERK and ATF6-Mediated Reticulophagy

Mfn2 is responsible for inhibition of the RIG-I/IRF7 pathway and activation of NLRP3 inflammasome in Seneca Valley virus-infected PK-15 cells to promote viral replication

Allosteric regulation of Senecavirus A 3C pro proteolytic activity by an endogenous phospholipid

2B and 3C Proteins of Senecavirus A Antagonize the Antiviral Activity of DDX21 via the Caspase-Dependent Degradation of DDX21